Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
about
Cytomegalovirus positive ulcerative colitis: A single center experience and literature review.Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis.Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients.Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study.
P2860
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@en
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@nl
type
label
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@en
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@nl
prefLabel
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@en
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@nl
P2860
P356
P1476
Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.
@en
P2093
Manuel Pascual
Nancy Perrottet
P2860
P304
P356
10.1586/ERI.11.116
P50
P577
2011-11-01T00:00:00Z